Kaplan-Meier survival analysis showed significant differences in (A) cancer-specific survival (CSS) and (B) relapse-free survival (RFS) among three groups, namely the pN0, pMLN metastasis and LPLN-positive groups, after CRT. MLN, mesorectal lymph nodes; LPLN, lateral pelvic lymph nodes; CRT, chemoradiotherapy.